No abstract available
Keywords:
Anti-VEGF agents; Proteinuria; Renal carcinoma; Reversible posterior leukoencephalopathy syndrome; Tyrosine kinase inhibitors.
MeSH terms
-
Axitinib
-
Carcinoma, Renal Cell / drug therapy*
-
Everolimus / administration & dosage
-
Everolimus / therapeutic use
-
Fatal Outcome
-
Female
-
Humans
-
Imidazoles / administration & dosage
-
Imidazoles / therapeutic use
-
Indazoles / administration & dosage
-
Indazoles / therapeutic use
-
Kidney Neoplasms / drug therapy*
-
Magnetic Resonance Imaging
-
Middle Aged
-
Nephrotic Syndrome / chemically induced*
-
Posterior Leukoencephalopathy Syndrome / chemically induced*
-
Posterior Leukoencephalopathy Syndrome / diagnostic imaging
-
Pyrimidines / administration & dosage*
-
Pyrimidines / adverse effects
-
Sulfonamides / administration & dosage*
-
Sulfonamides / adverse effects
Substances
-
Imidazoles
-
Indazoles
-
Pyrimidines
-
Sulfonamides
-
pazopanib
-
Everolimus
-
Axitinib